"Weight loss and changes in nutritional status, common consequences of GLP-1 receptor agonist therapy, are established risk factors for telogen effluvium, a common and typically transient form of non-scarring hair loss, providing a plausible biological mechanism for this association," write the researchers
Patients typically experience reduced appetite and feel satisfied with smaller portions -- making it easier to maintain a calorie deficit without constant willpower battles
Tirzepatide is a new type of medication used to help people with type 2 diabetes control their blood sugar levels
Read more Best Glutathione Serums for Bright Skin
Yes, appetite suppression begins within days, but measurable weight loss on the scale typically appears within 4 to 8 weeks
10.1016/j.jpainsymman.2006.12.010 6 BernhardsonB.-M.TishelmanC.RutqvistL